Study Finds Possible Overlooked Risk Factor for Heart Attack

New study results presented at the annual meeting suggest that immunoglobulin G4 (IgG) antiphospholipid antibody positivity may be an important but overlooked risk factor for myocardial infarction (MI).

Study Finds That Intensity of Walking Affects Risk of Knee Replacement

Patients with knee osteoarthritis (OA) who walk with moderate to vigorous intensity may lower their risk of total knee arthroplasty (TKA), according to new research presented at the annual meeting.

Associations Jointly Present Draft of First Classification Criteria for IgG4-related Disease

The American College of Rheumatology (ACR) and European League Against Rheumatism have presented a draft of “Classification Criteria for IgG4-related Disease,” the first classification criteria developed for the recently recognized disease. The criteria were unveiled during a session at the annual meeting, and they are under review by both associations for endorsement.

Women Abused During Childhood Have Significantly Higher Risk of Lupus

According to research presented at the annual meeting, women who experienced physical or emotional abuse in childhood have a significantly higher risk of developing systemic lupus erythematosus (SLE) in adulthood.

Treatment of Patients with AS, PsA, and PsO

During the annual meeting, a standing-room-only audience attended a product theater on Cosentyx® (secukinumab), manufactured by Novartis, which is used to treat several forms of spondyloarthritis.

A Divorce Between Psoriatic Arthritis and Rheumatoid Arthritis

At a dinner symposium hosted by Novartis at the annual meeting, a panel of experts explained the irreconcilable differences between psoriatic arthritis (PsA) and rheumatoid arthritis (RA).